Assessing the Feasibility of Screening and Treating Anxiety and Depression in the Bone Marrow Transplant Population
Completed
Conditions studied: Anxiety, Depression
In brief
The primary purpose of this study is twofold: (1) to assess the feasibility of screening adult hematopoietic stem cell transplantation (HSCT) candidates for psychiatric comorbidity (depression and anxiety), and (2) to assess the feasibility of treating depression and anxiety in adult HSCT candidates through a collaborative care algorithm. The ultimate goal of this project is improving HSCT outcomes for allogeneic HSCT candidates by improving identification and treatment of depression and anxiety disorders.
Key facts
- Study ID
- NCT04025190
- Run by
- UNC Lineberger Comprehensive Cancer Center
- People needed
- 20
- Starts
- 2018-02-22
- Expected to finish
- 2018-08-28
- Last updated by the study team
- 2019-07-18
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- hematological or non-hematological malignancy
- plan to receive an allogeneic stem cell transplant
- patient at UNC's ambulatory BMT clinic
- able to complete self-report measures
- English speaking
You may not qualify if…
- plan to receive an autologous transplant
- plan to receive allogeneic transplant for a non-malignancy
- unable to complete self report measures in English
- pregnant
- pre-existing diagnoses of bipolar affective disorder, schizoaffective disorder or schizophrenia
Where it is running
- Eliza Park, MD — Chapel Hill, North Carolina, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.